The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring.

In this recent episode of AHA’s Advancing Health podcast, Sara Robinson, senior associate healthcare architect at McMillan ...

Artificial intelligence image generators are perhaps less suited for practical needs than they are for creating a dreamer's ...

The maker of the FDA’s only approved total artificial heart has outlined plans to go public, with a $12 million IPO, ...

From designing the curriculum to recruiting faculty and students, building a medical school from the ground up is a unique ...

While hiring interior designers for aesthetic medical offices is a growing trend, many other specialties haven’t really ...

So, taking all of that into account, the best time to take your blood pressure for most people will be in the morning — more ...

Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal ...

It’s all something any nutrition coach might encounter—except, at Good Nutrition, patients can now pay using their HSA or FSA ...

RIT gives Alfred Davis Awards to a teacher and student for their work on campus and volunteerism in the community.

Since the onset of the COVID-19 pandemic, vaccination rates for both children and adults have declined. Public trust in vaccines was deeply shaken by politics during the pandemic.